First doses of Bavarian Nordic’s Mpox vaccine now arriving in the Democratic Republic of Congo Page 1

• Vaccine donations from the European Commission, US government and Bavarian Nordic are now reaching the DRC, the epicentre of the mpox outbreak
• More than 250,000 doses will arrive in the coming week, marking a crucial turning point in the fight against mpox in Africa

COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that the first doses of its mpox vaccine, MVA-BN, also known as JYNNEOS, arrived in the Democratic Republic of Congo (DRC) today. Additional deliveries to the DRC are planned in the coming week, adding to a total of more than 250,000 vaccines donated by the European Commission’s Health Emergency Preparedness and Response Authority (HERA), the U.S. government and Bavarian Nordic.

The vaccines delivered today represent the first MPOX vaccines to DRC, marking a turning point in the collective efforts of Africa CDC and the international community to combat the outbreak and bring life-saving vaccines to those who need it most. While broader deployment of the vaccine in Africa is pending emergency authorization from the World Health Organization (WHO), DRC health authorities have already granted national emergency authorization for MVA-BN, allowing for immediate deployment.